Vidavo S.A. designs, develops, and provides connected health, wellness, and healthy ageing solutions. More Details
Flawless balance sheet and slightly overvalued.
Share Price & News
How has Vidavo's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: VIDAVO is more volatile than 75% of Greek stocks over the past 3 months, typically moving +/- 9% a week.
Volatility Over Time: VIDAVO's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of Greek stocks.
7 Day Return
GR Healthcare Services
1 Year Return
GR Healthcare Services
Return vs Industry: VIDAVO exceeded the Greek Healthcare Services industry which returned 13.6% over the past year.
Return vs Market: VIDAVO exceeded the Greek Market which returned -15.9% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Vidavo's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StVidavo S.A.'s (ATH:VIDAVO) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
3 months ago | Simply Wall StVidavo S.A.'s (ATH:VIDAVO) Shares Climb 32% But Its Business Is Yet to Catch Up
Is Vidavo undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: VIDAVO (€5.4) is trading below our estimate of fair value (€19.03)
Significantly Below Fair Value: VIDAVO is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: VIDAVO is poor value based on its PE Ratio (50x) compared to the European Healthcare Services industry average (46.2x).
PE vs Market: VIDAVO is poor value based on its PE Ratio (50x) compared to the Greek market (21.7x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate VIDAVO's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: VIDAVO is overvalued based on its PB Ratio (6.8x) compared to the XE Healthcare Services industry average (4.7x).
How is Vidavo forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Vidavo has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Vidavo performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: VIDAVO has high quality earnings.
Growing Profit Margin: VIDAVO's current net profit margins (29.7%) are lower than last year (36.3%).
Past Earnings Growth Analysis
Earnings Trend: VIDAVO has become profitable over the past 5 years, growing earnings by 11.7% per year.
Accelerating Growth: VIDAVO's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: VIDAVO had negative earnings growth (-9%) over the past year, making it difficult to compare to the Healthcare Services industry average (24%).
Return on Equity
High ROE: VIDAVO's Return on Equity (13.5%) is considered low.
How is Vidavo's financial position?
Financial Position Analysis
Short Term Liabilities: VIDAVO's short term assets (€1.3M) exceed its short term liabilities (€745.9K).
Long Term Liabilities: VIDAVO's short term assets (€1.3M) exceed its long term liabilities (€118.4K).
Debt to Equity History and Analysis
Debt Level: VIDAVO is debt free.
Reducing Debt: VIDAVO has not had any debt for past 5 years.
Debt Coverage: VIDAVO has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: VIDAVO has no debt, therefore coverage of interest payments is not a concern.
What is Vidavo current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate VIDAVO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate VIDAVO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if VIDAVO's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if VIDAVO's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: VIDAVO is not paying a notable dividend for the Greek market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of VIDAVO's dividend in 3 years as they are not forecast to pay a notable one for the Greek market.
How experienced are the management team and are they aligned to shareholders interests?
Mr. Pantelis A. Aggelidis serves as the Chairman and Chief Executive Officer of Vidavo S.A.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Vidavo S.A.'s company bio, employee growth, exchange listings and data sources
- Name: Vidavo S.A.
- Ticker: VIDAVO
- Exchange: ATSE
- Founded: 2002
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: €4.235m
- Shares outstanding: 857.21k
- Website: https://www.vidavo.eu
Number of Employees
- Vidavo S.A.
- Building D
- Balkan Center
- 570 01
Vidavo S.A. designs, develops, and provides connected health, wellness, and healthy ageing solutions. The company offers Vida24, a cloud based platform and customizable app that synchs multi-source data. I...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/07/29 21:39|
|End of Day Share Price||2021/07/29 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.